When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. FDA warns of potential risk from Hologic's devices implanted ...

   www.aol.com/news/fda-warns-potential-risk-ho...

   The company's devices, BioZorb Marker and BioZorb LP Marker, are implanted in soft tissue, including breast tissue, where the site needs to be marked for future procedures, such as radiation for ...

3. FDA classifies recall of Hologic's implant as 'most serious'

   www.aol.com/news/fda-classifies-recall-hologics...

   The FDA said the recall of the device BioZorb Marker, initiated by Hologic in March, was not a product removal, but a correction. The agency also urged patients to report any side effects they ...

4. Breast cancer management - Wikipedia

   en.wikipedia.org/wiki/Breast_cancer_management

   Upper-limb dysfunction is a common side effect of breast cancer treatment. [65] Shoulder range of motion can be impaired after surgery. Exercise can meaningfully improve should range of motion in women with breast cancer. [65] An exercise programme can be started early after surgery, if it does not negatively affect wound drainage. [65] [66] [67]

5. Mammography - Wikipedia

   en.wikipedia.org/wiki/Mammography

   In scans where women receive 0.25–20 Gray (Gy) of radiation, they have more of an elevated risk of developing breast cancer. [40] A study of radiation risk from mammography concluded that for women 40 years of age and older, the risk of radiation-induced breast cancer was minuscule, particularly compared with the potential benefit of ...

6. Breast and ovarian cancer - Wikipedia

   en.wikipedia.org/wiki/Breast_and_ovarian_cancer

   Women with a history of breast cancer have a higher chance of developing ovarian cancer, [1] vice versa. Breast cancer refers to the uncontrolled division of breast cells. It is possible for both males and females to get breast cancer. Breast cancer is the most common cancer women face. Ovarian cancer is a type of cancer which begins in the ...

7. Bayer recalls one lot of cancer drug Vitrakvi due to ... - AOL

   www.aol.com/news/bayer-recalls-one-lot-cancer...

   The company has not received any adverse event reports related to the lot to date, it said. The drug, Vitrakvi, is approved for use in patients who have advanced solid tumor cancers with a rare ...